PainReform (PRFX) Expected to Announce Quarterly Earnings on Thursday

PainReform (NASDAQ:PRFX) will likely be issuing its quarterly earnings data before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($4.74) per share for the quarter.

PainReform Price Performance

Shares of NASDAQ PRFX opened at $3.10 on Tuesday. The firm has a 50-day simple moving average of $3.25 and a two-hundred day simple moving average of $2.86. PainReform has a 1 year low of $1.73 and a 1 year high of $61.20. The company has a market cap of $449,500.00, a P/E ratio of -0.02 and a beta of 0.64.

PainReform Company Profile

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.